|
SE367181B
(enExample)
|
1969-05-14 |
1974-05-20 |
Takeda Chemical Industries Ltd |
|
|
US3644479A
(en)
*
|
1970-02-09 |
1972-02-22 |
Bristol Myers Co |
1-indancarboxylic acids and derivatives
|
|
US3663627A
(en)
*
|
1970-06-01 |
1972-05-16 |
Bristol Myers Co |
1-indanmethanols
|
|
CH585687A5
(enExample)
*
|
1972-08-24 |
1977-03-15 |
Ciba Geigy Ag |
|
|
DK464274A
(enExample)
*
|
1973-09-11 |
1975-05-12 |
Sandoz Ag |
|
|
FR2359135A1
(fr)
*
|
1976-07-22 |
1978-02-17 |
Hexachimie |
Nouvelles phenoxyhydroxypropylamines, procede pour les preparer et leur application en therapeutique
|
|
JPS6055071B2
(ja)
*
|
1982-04-16 |
1985-12-03 |
四国化成工業株式会社 |
イミダゾリル琥珀酸化合物および該化合物を用いるエポキシ樹脂硬化方法
|
|
JPS60105645A
(ja)
*
|
1983-11-12 |
1985-06-11 |
Yasumitsu Tamura |
アリ−ルコハク酸エステルの製造法
|
|
US4933398A
(en)
*
|
1987-07-01 |
1990-06-12 |
Ciba-Geigy Corporation |
Photosensitive epoxy resins and use thereof
|
|
DD271903A1
(de)
*
|
1988-05-17 |
1989-09-20 |
Univ Halle Wittenberg |
Verfahren zur herstellung stabiler, 2-unsubstituierter imidazol-3-oxide
|
|
WO1998031697A1
(en)
*
|
1997-01-15 |
1998-07-23 |
Sankyo Company, Limited |
Aryl c-glycoside compounds and sulfated esters thereof
|
|
ZA98376B
(en)
*
|
1997-01-23 |
1998-07-23 |
Hoffmann La Roche |
Sulfamide-metalloprotease inhibitors
|
|
US5804581A
(en)
*
|
1997-05-15 |
1998-09-08 |
Bayer Corporation |
Inhibition of matrix metalloproteases by substituted phenalkyl compounds
|
|
US6130220A
(en)
*
|
1997-10-16 |
2000-10-10 |
Syntex (Usa) Inc. |
Sulfamide-metalloprotease inhibitors
|
|
US20010039287A1
(en)
*
|
1997-11-14 |
2001-11-08 |
Thomas E Barta |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
|
US20010014688A1
(en)
*
|
1997-11-14 |
2001-08-16 |
Thomas E. Barta |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
|
AU1572399A
(en)
*
|
1997-12-17 |
1999-07-05 |
Chirotech Technology Limited |
Asymmetric hydrogenation
|
|
PA8469501A1
(es)
*
|
1998-04-10 |
2000-09-29 |
Pfizer Prod Inc |
Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico
|
|
ES2220004T3
(es)
*
|
1998-04-10 |
2004-12-01 |
Pfizer Products Inc. |
Derivados del acido ciclobutil-ariloxiarilsulfonilaminohidroxamico.
|
|
UA71586C2
(en)
*
|
1998-12-04 |
2004-12-15 |
Smithkline Beecham Corp |
A vitronectin receptor antagonist
|
|
AU775701B2
(en)
*
|
1999-02-08 |
2004-08-12 |
G.D. Searle & Co. |
Sulfamato hydroxamic acid metalloprotease inhibitor
|
|
CZ20013338A3
(cs)
*
|
1999-03-18 |
2002-03-13 |
Celgene Corporation |
Substituované 1-oxo-a l,3-dioxoisoindoliny a jejich pouľití ve farmaceutických prostředcích pro sníľení koncentrací zánětlivých cytokinů
|
|
JP2000271485A
(ja)
*
|
1999-03-24 |
2000-10-03 |
Kazuhiko Saigo |
オレフィン類のビスアルコキシカルボニル化触媒、及びコハク酸エステル誘導体の製造法
|
|
EP1165500A1
(en)
*
|
1999-04-02 |
2002-01-02 |
Du Pont Pharmaceuticals Company |
Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase
|
|
EP1181286B1
(en)
*
|
1999-05-28 |
2003-11-12 |
Pfizer Products Inc. |
3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
|
|
HN2000000052A
(es)
*
|
1999-05-28 |
2001-02-02 |
Pfizer Prod Inc |
Hidroxiamidas de acidos 3- (arilsulfonilamino)- tetrahidrofuran-3-carboxilicos.
|
|
US6387901B1
(en)
*
|
1999-07-06 |
2002-05-14 |
Pfizer Inc |
Alkyne containing metalloproteinase inhibitors
|
|
GB9916562D0
(en)
*
|
1999-07-14 |
1999-09-15 |
Pharmacia & Upjohn Spa |
3-Arylsulfonyl-2-(substituted-methyl) propanoic acid derivatives as matrix metalloproteinase inhibitora
|
|
US20010049449A1
(en)
*
|
1999-12-23 |
2001-12-06 |
Becker Daniel P. |
Aromatic sulfonyl alpha-cycloamino hydroxamates and their use as MMP inhibitors
|
|
US6458822B2
(en)
*
|
2000-03-13 |
2002-10-01 |
Pfizer Inc. |
2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
|
|
US20030114457A1
(en)
*
|
2001-07-09 |
2003-06-19 |
Axys Pharmaceuticals, Inc. |
2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
|
|
JP2006506446A
(ja)
*
|
2002-11-19 |
2006-02-23 |
ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ |
ＰＰＡＲ−γ型レセプターを活性化する新規二芳香族化合物、および化粧品組成物または薬剤組成物におけるその使用
|
|
BRPI0508098A
(pt)
*
|
2004-02-27 |
2007-07-17 |
Amgen Inc |
compostos, composições farmacêuticas e métodos para uso no tratamento de distúrbios metabólicos
|